Blood cancer continues to be a devastating disease, requiring ongoing research and support to advance treatments and improve access to care. Philanthropy plays a key role in driving innovation and expanding access, especially for underserved communities. In a recent interview, Lore Gruenbaum, VP of Research for The Leukemia & Lymphoma
In a recent interview, Mathew Cook, Senior Director Sales - UK, Ireland Nordics (Academia, Public & Pharma) at Merck Life Science | CSAM, talked with Muhammad Younis about the evolving landscape of advanced therapies, including cell and gene therapies. Mathew discussed the strategic shifts needed to make these innovations widely accessible,
September 2, 2024: Researchers at the Murdoch Children’s Research Institute in Melbourne and the University of Birmingham have achieved a major breakthrough in blood stem cell engineering. This innovative development successfully replicates blood stem cells similar to those found in the human body. By overcoming critical barriers in stem
The London Biotechnology Show returns for its highly anticipated second edition, building on the remarkable success of its debut. This year's event has significantly expanded its scope, offering an even richer array of content, product showcases, and innovations. The inaugural London Biotechnology Show was a major hit with
May 9, London: The curtain has closed on the debut London Biotechnology Show 2024, leaving attendees thoroughly impressed by the seamless delivery of promised content and exhibits. From massive exhibition to jam-packed conference sessions, from groundbreaking product launches to cutting-edge startup showcase, from insightful panel discussions to valuable networking opportunities,